Profile data is unavailable for this security.
About the company
BioStem Technologies, Inc. is focused on harnessing the natural properties of perinatal tissue in the development, manufacture and commercialization of allografts and regenerative therapies. Leveraging its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The Company's products include VENDAJE, VENDAJE AC, VENDAJE OPTIC and AMERICAN AMNION. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE AC is a thicker structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. It also owns BioTissue's surgical and wound care business, including the Neox and Clarix product lines.
- Revenue in USD (TTM)235.17m
- Net income in USD20.20m
- Incorporated2009
- Employees67.00
- LocationBiostem Technologies Inc2836 Center Port CirPOMPANO BEACH 33064-2136United StatesUSA
- Phone+1 (954) 380-8342
- Websitehttps://www.biostemtechnologies.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MindWalk Holdings Corp | 14.89m | -22.60m | 65.83m | 102.00 | -- | 5.04 | -- | 4.42 | -0.628 | -0.6098 | 0.3492 | 0.2798 | 0.4745 | 6.67 | 4.50 | -- | -72.01 | -32.32 | -90.53 | -36.45 | 58.50 | 55.79 | -151.78 | -100.97 | 4.09 | -23.68 | 0.17 | -- | 0.0082 | 11.77 | -11.25 | -- | 10.37 | -- |
| Scilex Holding Co | 40.36m | -375.84m | 66.74m | 30.00 | -- | -- | -- | 1.65 | -33.18 | -33.18 | 4.08 | -28.88 | 0.2145 | 7.27 | 1.85 | 350,956.50 | -177.73 | -- | -- | -- | 68.59 | 75.06 | -828.56 | -176.54 | 0.0429 | -3.76 | -- | -- | 21.07 | 21.89 | 56.40 | -- | -49.14 | -- |
| Pliant Therapeutics Inc | 0.00 | -175.50m | 66.98m | 171.00 | -- | 0.3344 | -- | -- | -2.87 | -2.87 | 0.00 | 3.26 | 0.00 | -- | -- | 0.00 | -48.60 | -38.70 | -52.81 | -41.26 | -- | -- | -- | -1,044.87 | -- | -- | 0.1319 | -- | -100.00 | -- | -30.35 | -- | 31.90 | -- |
| Pelthos Therapeutics Inc | 7.41m | -23.58m | 71.98m | 4.00 | -- | 1.24 | -- | 9.72 | -17.09 | -17.09 | 6.02 | 18.85 | 0.1152 | -- | -- | 1,851,500.00 | -36.68 | -- | -47.05 | -- | 68.73 | -- | -318.41 | -- | 1.04 | -12.32 | 0.00 | -- | -- | -- | -7.78 | -- | -- | -- |
| Polypid Ltd | 0.00 | -34.22m | 72.36m | 57.00 | -- | 4.71 | -- | -- | -2.98 | -2.98 | 0.00 | 0.9237 | 0.00 | -- | -- | 0.00 | -147.37 | -90.05 | -241.51 | -109.86 | -- | -- | -- | -- | -- | -22.38 | 0.1359 | -- | -- | -- | -21.61 | -- | -38.71 | -- |
| Assertio Holdings Inc | 137.35m | -28.92m | 74.56m | 58.00 | -- | 0.7047 | 33.79 | 0.5429 | -4.71 | -4.71 | 20.93 | 16.49 | 0.4611 | 1.35 | 1.47 | 2,368,138.00 | -9.71 | -15.74 | -17.07 | -24.19 | 68.16 | 82.29 | -21.06 | -42.01 | 1.43 | -- | 0.2702 | -- | -17.83 | -11.45 | 93.50 | -- | -- | -- |
| Fortress Biotech Inc | 62.30m | -5.34m | 90.94m | 101.00 | -- | 1.63 | -- | 1.46 | -0.293 | -0.293 | 2.16 | 1.80 | 0.4039 | 1.50 | 4.35 | 616,861.40 | -34.90 | -54.95 | -51.59 | -102.13 | 71.56 | 62.39 | -86.41 | -227.71 | 1.97 | -10.63 | 0.4503 | -- | -31.76 | 9.50 | 18.61 | -- | 25.88 | -- |
| NovaBay Pharmaceuticals Inc | 2.83m | -7.95m | 94.86m | 14.00 | -- | -- | -- | 33.52 | -1.58 | 0.5377 | 0.555 | 0.2718 | 0.7686 | -- | 5.28 | 202,142.90 | -215.92 | -61.58 | -404.37 | -83.79 | 54.56 | 59.49 | -280.92 | -77.39 | -- | -91.56 | 0.0836 | -- | -33.58 | 8.19 | 48.52 | -- | -20.59 | -- |
| Alpha Cognition Inc | 7.43m | -19.47m | 97.84m | 52.00 | -- | 2.16 | -- | 13.17 | -1.37 | -1.37 | 0.5002 | 2.09 | 0.2894 | -- | 5.22 | 142,830.80 | -75.87 | -119.10 | -93.86 | -159.05 | 73.09 | -- | -262.18 | -- | 6.03 | -7.91 | 0.00 | -- | -- | -- | -6.34 | -- | -- | -- |
| Verrica Pharmaceuticals Inc | 30.83m | -26.01m | 105.69m | 71.00 | -- | -- | -- | 3.43 | -3.44 | -3.44 | 3.50 | -1.80 | 0.8352 | 1.09 | 8.75 | 434,211.30 | -70.48 | -71.91 | -217.79 | -111.91 | 91.36 | -- | -84.38 | -729.00 | 1.18 | -1.70 | 1.94 | -- | 47.66 | -- | -14.31 | -- | -47.58 | -- |
| Karyopharm Therapeutics Inc | 142.53m | -124.62m | 111.51m | 279.00 | -- | -- | -- | 0.7824 | -14.58 | -14.58 | 16.69 | -30.94 | 0.9977 | 1.34 | 4.48 | 510,860.20 | -87.24 | -48.75 | -181.85 | -63.64 | 95.93 | 97.09 | -87.43 | -92.03 | 0.9842 | -2.55 | -- | -- | -0.5451 | 28.85 | 46.60 | -- | -7.17 | -- |
| Biostem Technologies Inc | 235.17m | 20.20m | 112.78m | 67.00 | 7.45 | 2.25 | 5.52 | 0.4796 | 0.9019 | 0.9019 | 11.60 | 2.98 | 2.82 | 2.61 | 4.65 | -- | 24.25 | -- | 55.07 | -- | 97.33 | -- | 8.59 | -- | 4.09 | -- | 0.0566 | -- | 1,708.93 | -- | 475.86 | -- | -- | -- |
| Whitehawk Therapeutics Inc | 14.38m | -15.62m | 127.72m | 22.00 | 19.95 | 0.8126 | -- | 8.88 | 0.1358 | 0.1358 | 0.2802 | 3.33 | 0.1138 | 0.5669 | 4.40 | 359,600.00 | -12.36 | -52.97 | -13.76 | -60.63 | 89.22 | -- | -108.58 | -372.67 | 16.76 | -- | 0.00 | -- | 6.69 | -- | 3.15 | -- | 47.49 | -- |
| NDT Pharmaceuticals Inc | -100.00bn | -100.00bn | 152.00m | 1.00 | -- | 0.8486 | -- | -- | -- | -- | -- | 1.12 | -- | -- | -- | -- | -- | -164.47 | -- | -452.47 | -- | -- | -- | -6,891.36 | -- | -- | 0.00 | -- | -100.00 | -- | 87.56 | -- | -- | -- |
